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Background: Outcomes after endovascular repair for iliac artery (IA) in-stent restenosis
(ISR) are not known. The purpose of this study is to evaluate procedural and mid-term
clinical outcomes following endovascular treatment of IA-ISR.
Methods: 41 endovascular procedures (24 patients) were performed for IA-ISR. Clinical
and procedural outcomes were retrospectively analyzed including 6 and 12-month
primary patency (50% stenosis at the treatment site by duplex ultrasonography without
the need for re-intervention).
Results: Patient and procedural indices are summarized in table 1. The majority of lesions
was unilateral and involved the common iliac artery (65.7%). Mean length of ISR was
30.1  14.1 mm with Type I (focal) and II (diffuse) ISR being the predominant patterns.
All patients underwent balloon angioplasty and adjunctive stenting was performed in
65.7% of the procedures. Type II ISR lesions were more likely to be stented (13/16
lesions, p  0.02). Procedural success was achieved in 100% of cases with a mean gain
of 0.13 in ankle-brachial index (p 0.001) at one month follow up. The 6 and 12-month
primary patency rates were 96% and 82%, respectively. 12-month primary assisted
patency rate was 88% with a need for target vessel revascularization (TVR) in 10%.
Overall survival rate was 92% at 12 months with no limb loss.
Conclusions: Endovascular treatment of IA-ISR is associated with high patency rates
and low risk of target TVR at one year.
Patient Characteristics (n  24)
Patient Characteristics (n  24)
Age (years, Mean  SD) 58.5  11.1
Male Gender 37.5%
DM 37.5%
CAD 37.5%
Hypertension 87.5%
Active Smoking 58.5%
LDL (mg/dl, mean  SD) 75  33
eGFR (ml/min) 78  31
Aspirin 95.8%
Clopidogrel 62.5%
Dual Antiplatelet 62.2%
Statin 83.3%
Preprocedure Rutherford Class
3 66.6%
4 33.4%
Postprocedure Rutherford Class
3 80.0%
4 20.0%
ABI
Preprocedure (median, IQR) 0.75 (0.66, 0.93)
Postprocedure 1 month (median, IQR) 0.87 (0.80, 1.01)
Lesion and Procedural Indices (n  41)
Original TASC
A 46.3%
B 34.1%
C 15.6%
D 4.0%
Indication
Acute Limb Ischemia 9.7%
Critical Limb Ischemia 19.5%
Claudication 39.1%
Duplex Surveillance 31.7%
ISR Type
1 (focal,  20 mm) 34.1%
2 (diffuse, 20 mm) 39.0%
3 (proliferative) 17.1%
Patient Characteristics (n  24)
4 (occlusion) 9.7%
Lesion Length (mm, Mean  SD) 30.1  14.0
Artery Diameter (mm, Mean  SD) 7.2  1.1
Lesion Location
Common Iliac Artery 65.9%
External Iliac Artery 34.1%
Bilateral Disease 25.0%
Intervention Performed
Balloon Angioplasty 78.0%
Cutting Balloon 17.1%
Re-stenting 27 (65.7%)
Covered 19 (46.3%)
Non-covered 8 (19.4%)
Patency (Duplex Ultrasound, Stenosis
50%, PSV ratio 2)
6 months
Primary 96%
12 months
Primary 84%
Primary Assisted 88%
TVR
6 months 0
12 months 10%
Amputation 0
Fluoroscopy time (min) 15.4  11.7
Contrast (ml) 150  72.2
Death 8.3%
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Background: In-stent restenosis (ISR) after superficial femoral artery (SFA) stenting remains
an unsolved problem. Recently, there is an attempt to predict clinical outcomes using
angiographic restenotic pattern. The purpose of this study was to investigate the long term
outcome of endovascular treatment of SFA ISR according to angiographic pattern.
Methods: A single institution retrospective chart review study was performed for patients
who were diagnosed with SFA-ISR by angiographic method from March 2002 to March 2011
and 61 restenotic lesions in 57 patients were enrolled. We classified SFA-ISR by angiographic
pattern: group I (totally occluded ISR, n49) and group II (focal or diffuse lesions, n12).
Recurrent ISR or occlusion was defined as ISR or occlusion after target lesion revasculariza-
tion.
Results: Seventy-two percent of patients were male, 51% had diabetes, and 25% had
chronic renal failure. Median follow up duration was 385 days [interquartile range:
162-703]. Baseline characteristics between two groups were similar. Technical success
was lower in group I compared with group II (88.9% vs. 100%, p0.227), but was not
statically significant. Long term recurrent ISR rate were not different between two groups
calculated by Kaplan-meier method (log rank p0.368), but group I tend to be recur
occlusivly compared with group II (40% vs. 8.3%, p0.040).
Conclusions: SFA-ISR with total occlusion tends to be treated by surgical method. But
after managed with endovascular method, totally Occluded SFA ISR does not worsen the
mid term outcomes, but tend to recur occlusively.
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